Why does this page look this way?
It appears that you are using either an older, classic Web browser or a hand-held device that allows you to view our content but may not work with every feature of our site. If you are using an older browser, please upgrade for the best experience.
Navigation
home > by publication type > daily analysis > Challenges Rise in the Fight Against TB
| Prepared by: |
|---|
Treating drug-resistant strains has proved especially difficult due to cost. (AP Images/Mahesh Kumar A)
Andrew Speaker, an Atlanta lawyer infected with a highly drug-resistant strain of tuberculosis (XDR-TB), ignited a media firestorm and a minor health panic in the United States. His ability to enter the United States against the advice of the U.S. Centers for Disease Control called attention to problems with interagency coordination on infectious disease cases (PDF). Michael Osterholm, a disaster planning expert, said the case raises concerns about what would happen in “the opening days of a flu pandemic (USAToday).” Some health experts say the actual danger posed by the Speaker case was “overblown (AJC).” They add, however, that the risk posed by the rise of drug resistant TB is quite serious.
According to data from a report (PDF) by Doctors Without Borders, about nine million active infections of TB develop annually, leading to about two million deaths. TB is one of the most common infections among the HIV infected and the top killer of people with AIDS globally. A World Health Organization report finds the rise in drug-resistant TB strains corresponds with the world’s fastest-growing HIV infection rates. Multidrug resistant strains of TB (MDR-TB) are particularly deadly and number up to 424,000 annually, with XDR-TB infecting as many as 30,000. The XDR-TB strain is so drug resistant the estimated cure rate is only 30 percent. Its existence was confirmed just last year and has now been diagnosed in 37 countries. A 2007 report card from Global Health Advocates, a nonprofit group against "diseases of poverty," shows which countries are at "significant risk" of developing MDR-TB on a large scale.
Treating these strains is complicated because of the longer treatment time, increased side-effects, lack of effective secondary drug options, and significant financial cost. Drug treatments and diagnostic tests for TB are also several decades old. Health advocates point out that most drug research focuses on curing ailments common in the lucrative markets of the United States and Europe. But a new discussion is opening among pharmaceutical companies and nonprofit groups about the profitability of treating TB (BaltSun). “There’s more going on in TB drug development now than there has been in decades,” Al Hinman, a spokesman for the TB Alliance, told the Sun. Accordingly, the WHO recently laid out a $2 billion plan aiming to provide access to drugs and diagnostic tests to all MDR-TB and XDR-TB patients by 2015.
TB represents just one of several diseases emerging as a drug-resistant threat. For example, health advocates point to an alarming increase in the number of antibiotic resistant staph infections (Science Daily). A recent report (PDF) from the European Centre for Disease Prevention and Control notes that “antimicrobial resistance is one of the most serious public health problems, globally and in Europe.” Compounding this problem is the speed at which disease can now travel. A recent National Academies of Sciences report points out that disease can now circle the globe with “near telephonic speed, making long-distance connections and intercontinental infections almost as if by satellite.”
Weigh in on this issue by emailing CFR.org.
To order Task Force reports, Council Special Reports, and Critical Policy Choices, please call, fax, or order online from our distributor, the Brookings Institution Press: phone +1.800.537.5487, fax +1.410.516.6998.
For information on other reports that are not for sale, or for general publications information, please call +1.212.434.9516 or email publications@cfr.org.
Start-Up Nation addresses the trillion-dollar question: How is it that Israel—a country of 7.1 million, only sixty years old, surrounded by enemies— produces more start-up companies than large, peaceful, and stable nations like Japan, China, India, Korea, Canada, and the UK? With the insights of geopolitical experts and investors, the authors examine this nation’s adversity-driven culture to answer this question and offer prescriptions for a global economy on the rebound.
In Forces of Fortune, Vali Nasr presents a paradigm-changing revelation that will transform the understanding of the Muslim world at large. He reveals that there is a vital but unseen rising force in the Islamic world—a new business-minded middle class—that is building a vibrant new Muslim world economy and that holds the key to winning the cold war against Iran and extremists.
In Cuba: What Everyone Needs to Know, Julia E. Sweig presents a remarkably accessible portrait of Cuba's unique place on the world stage over the past fifty years, including its internal politics, its often fraught relationship with the United States, and its shifting relationship with the global community.
Complete list of CFR Books
The report of this bipartisan Task Force of distinguished leaders and experts represents a strong consensus on the importance of repairing America's immigration policy. It makes the case that maintaining America's political and economic leadership depends on attracting talented and hard-working immigrants, and on securing the country's borders in a smart, effective, and humane way.
This report finds that nuclear weapons will remain a fundamental element of U.S. national security in the near term, and makes recommendations on how to ensure the safety, security, and reliability of the U.S. deterrent nuclear force, prevent nuclear terrorism, and strengthen the nuclear nonproliferation regime.
About Independent Task Forces at CFR
Complete list of Task Force reports
Identifying international threats and acting on them may be the most difficult job for U.S. policymakers. This report
provides an actionable road map for managing international threats before they erupt into crises and makes a strong case that preventive action is not a luxury but a necessity.
For more than a decade, the United States has mostly watched from the sidelines as Asian countries organize themselves into an alphabet soup of new multilateral groups. In this report, the authors review the relationship between pan-Asian and trans-Pacific institutions and suggest policy guidelines for a new U.S. approach to this new Asian landscape.
Complete list of Council Special Reports
To request permission to reprint or reuse CFR material, please fill out this permissions request form (PDF), referring to the instructions on page 1.
Browse Content By Region IssuePublication TypeThe Think TankFor The MediaFor Educators About CFR
Copyright 2009 by the Council on Foreign Relations. All Rights Reserved.
